Poland: New draft act on clinical trials of human use medicinal products

In brief

On the beginning of May we sent a newsletter regarding the draft act on clinical trials of medicinal for human use that implements the Regulation 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC ("Regulation").

On 17 January the new version has been published in a public domain ("Draft").


Contents

General comments

First of all, the Draft is still on an early stage of the legislation process, thus it will not come in force by 31 January 2022, when the Regulation comes in force. The Draft assumes to come in force within 30 days as of the date of its publication.

The most important changes introduced in the current version of the draft regard:

  • the timelines for ethical review - this section has been completely modified as compared to the initial version;
  • creation of the Clinical Trials Compensation Fund at the disposal of Patients Ombudsman in place of Clinical Trial Participant Protection Fund at the disposal of the President of Medical Research Agency, along with reduction in the maximum amounts of compensation benefits for bodily injury, health disorder or death;
  • introduction of the "compassionate use" procedure into the Polish legal system.

Click here to access the full alert.

Polish version


Copyright © 2022 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.